These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 33643296)

  • 1. Advances in Modeling the Immune Microenvironment of Colorectal Cancer.
    Yoon PS; Del Piccolo N; Shirure VS; Peng Y; Kirane A; Canter RJ; Fields RC; George SC; Gholami S
    Front Immunol; 2020; 11():614300. PubMed ID: 33643296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer.
    Subtil B; Cambi A; Tauriello DVF; de Vries IJM
    Front Immunol; 2021; 12():724883. PubMed ID: 34691029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy.
    Kamal Y; Schmit SL; Frost HR; Amos CI
    Immunotherapy; 2020 Oct; 12(14):1083-1100. PubMed ID: 32787587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor immune microenvironment and nano-immunotherapeutics in colorectal cancer.
    Xiong Y; Wang Y; Tiruthani K
    Nanomedicine; 2019 Oct; 21():102034. PubMed ID: 31207314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of the relationship between ubiquitin-specific protease 21 (USP21) and prognosis, tumor microenvironment infiltration, and therapy response in colorectal cancer.
    Nie H; Yu Y; Wang F; Huang X; Wang H; Wang J; Tao M; Ning Y; Zhou J; Zhao Q; Xu F; Fang J
    Cancer Immunol Immunother; 2024 Jun; 73(8):156. PubMed ID: 38834869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of the Tumor Microenvironment and Treatment Strategies in Colorectal Cancer.
    Chen Y; Zheng X; Wu C
    Front Immunol; 2021; 12():792691. PubMed ID: 34925375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.
    Nenkov M; Ma Y; Gaßler N; Chen Y
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases.
    Ceelen W; Ramsay RG; Narasimhan V; Heriot AG; De Wever O
    Trends Cancer; 2020 Mar; 6(3):236-246. PubMed ID: 32101726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of innate and adaptive immunity in colorectal cancer.
    Grizzi F; Bianchi P; Malesci A; Laghi L
    World J Gastroenterol; 2013 Jan; 19(2):174-84. PubMed ID: 23345940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer.
    Ge P; Wang W; Li L; Zhang G; Gao Z; Tang Z; Dang X; Wu Y
    Biomed Pharmacother; 2019 Oct; 118():109228. PubMed ID: 31351430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance.
    Mola S; Pandolfo C; Sica A; Porta C
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Differentially-Expressed Homeobox Family Genes on the Prognosis and HOXC6 on Immune Microenvironment Orchestration in Colorectal Cancer.
    Qi L; Ye C; Zhang D; Bai R; Zheng S; Hu W; Yuan Y
    Front Immunol; 2021; 12():781221. PubMed ID: 34950145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy in colorectal cancer.
    Agarwal P; Le DT; Boland PM
    Adv Cancer Res; 2021; 151():137-196. PubMed ID: 34148613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of the intratumoral microbiota in colorectal cancer immunotherapy.
    Fan S; Zhang W; Zhou L; Wang D; Tang D
    Int Immunopharmacol; 2024 Aug; 137():112537. PubMed ID: 38909493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of Primary Human Colorectal Cancer Microenvironment Using a Perfusion Bioreactor-Based 3D Culture System.
    Manfredonia C; Muraro MG; Hirt C; Mele V; Governa V; Papadimitropoulos A; Däster S; Soysal SD; Droeser RA; Mechera R; Oertli D; Rosso R; Bolli M; Zettl A; Terracciano LM; Spagnoli GC; Martin I; Iezzi G
    Adv Biosyst; 2019 Apr; 3(4):e1800300. PubMed ID: 32627426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal multicellular organoids to study colorectal cancer.
    Idris M; Alves MM; Hofstra RMW; Mahe MM; Melotte V
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188586. PubMed ID: 34216725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between ferroptosis-related patterns and tumor microenvironment in colorectal cancer.
    He C; Gu X; Dong C; Xu Z; Liu L; Jiang B; Lu Y; Jiang X; Lu Z
    Int Immunopharmacol; 2024 Jun; 134():112258. PubMed ID: 38744178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
    Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
    IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment-associated gene C3 can predict the prognosis of colorectal adenocarcinoma: a study based on TCGA.
    Liu Y; Wang X
    Clin Transl Oncol; 2021 Sep; 23(9):1923-1933. PubMed ID: 33765255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.